logo-loader
viewAtomo Diagnostics Ltd

Atomo Diagnostics with Proactive at the ASX Small and Mid-Cap Conference 2020

Atomo Diagnostics Ltd's (ASX:AT1) John Kelly and Will Souter speak to Proactive's Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. Atomo's an Australian-headquartered medical device company with a sole focus on improving point-of-care diagnostics and delivering what they describe as a much more 'consumer-friendly and fit-for-purpose solution' in the community.

Quick facts: Atomo Diagnostics Ltd

Price: 0.35 AUD

ASX:AT1
Market: ASX
Market Cap: $196.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Oriole Resources posts a profit for the first half of the year

Oriole Resources PLC's (LON:ORR) Tim Livesey and Bob Smeeton talk to Proactive London about their interim results for the first half of 2020. Livesey discusses the highlights which include the securing of the Senala licence in Senegal for a further 10 years. Smeeton explains the financials...

11 minutes ago

2 min read